Cytomegalovirus Antibody Igg Negative

Lab Reagents

Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus antibody igg negative reagents distributed by Genprice. The Cytomegalovirus Antibody Igg Negative reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Antibody Group: Igg Negative

Igg Negative information

ELISA kit for Human Anti-Cytomegalovirus IgG (Anti-CMV IgG)

KTE62709-96T 96T
EUR 686.4
Description: Quantitative sandwich ELISA for measuring Human Anti-Cytomegalovirus IgG (Anti-CMV IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human anti-cytomegalovirus (CMV) antibody ( IgG)

EK0143 96 tests
EUR 723.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human anti-cytomegalovirus (CMV) antibody ( IgG) in samples from serum, plasma, tissue homogenates and other biological fluids.

Cytomegalovirus pp65 Antibody

abx021650-1mg 1 mg
EUR 1387.2

Anti-Cytomegalovirus antibody

STJ16100359 1 mL
EUR 1120.8

Human Cytomegalovirus (CMV) IgG ELISA Kit (Direct EIA)

EK7032 96wells/kit, with removable strips.
EUR 573.6

Human anti-cytomegalovirus IgG ,anti-CMV ELISA Kit

YLA4265HU-48T 48T
EUR 435

Human anti-cytomegalovirus IgG ,anti-CMV ELISA Kit

YLA4265HU-96T 96T
EUR 562.5

Zika IgM/IgG Control Pack (IgM,IgG & Negative Controls, 0.25mL)

0801020 0.25mL
EUR 122.4
Description: Please contact Gentaur in order to receive the datasheet of the product.

Zika IgM/IgG Control Pack (IgM,IgG & Negative Controls, 0.25mL)

801020 0.25mL
EUR 63

Mouse antibody for Cytomegalovirus

887 100 ug
EUR 431.93
Description: This is Mouse monoclonal FITC conjugated antibody against Cytomegalovirus pp65 for WB, ELISA.

Anti-Human Cytomegalovirus antibody

STJ16100451 1 mL
EUR 1092

Anti-Cytomegalovirus p65 antibody

STJ16101049 100 µg
EUR 424.8

Anti-Cytomegalovirus p65 antibody

STJ16101050 100 µg
EUR 424.8

Anti-Cytomegalovirus p65 antibody

STJ16101051 100 µg
EUR 424.8

Cytomegalovirus Antibody / CMV / PP65

V2332-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332-20UG 20 ug
EUR 219
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332SAF-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.